Tag: CBT > CBD FDA: Page 3

SAFE Banking Act

‘The Clash Between State and Federal Law in the Cannabis Industry’: 4 Key Takeaways on Federal Policy Reform Efforts

Cozen O’Connor attorneys share insight on where cannabis policy reform might be headed to address the disconnect between federal prohibition and state-legal programs.

June 24, 2022

Compliance

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD

The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act.

May 27, 2022

Hemp Research

New Study Addresses FDA's Concerns, Demonstrates CBD's Safety Profile

The study found that oral consumption of CBD does not negatively impact the liver or cause male reproductive toxicity and drowsiness.

May 19, 2022

Hemp Research

What’s Up With Pet CBD?

As consumer interest in cannabinoids for pets increases, so do questions about capitalizing on the growing market.

May 11, 2022

Compliance

Selling Hemp-Derived Delta-9 THC Products? Here's What to Consider

Marshall Custer of Husch Blackwell law firm dives into legal considerations for hemp businesses selling these products.

May 10, 2022

Interviews & Opinion

FDA Issues First Batch of Warning Letters to Delta-8 THC Product Manufacturers

The federal agency is warning five companies that they are marketing unapproved new drugs, misbranding their wares and unlawfully adding delta-8 THC to food products.

May 6, 2022

CBD Industry

Reflecting on 10 Years in the CBD Industry

The founders of Charlotte’s Web met Charlotte Figi, the company’s namesake, in 2012 and have since witnessed explosive growth in the industry. Now, they’re looking ahead at what’s to come for the company and industry as a whole.

April 8, 2022

Legislation and Regulation

FDA Issues Warning Letters to Companies Claiming Their CBD Products Can Treat COVID-19

The federal agency is warning seven companies that they are falsely advertising their wares.

April 1, 2022

Interviews & Opinion

FDA’s Rejection of CBD New Dietary Ingredient Notifications: Four Practical Takeaways

Kelley Drye & Warren’s Kristi Wolff breaks down the most important aspects of the government agency’s decision on the hemp-derived cannabinoid.

September 17, 2021

Legislation and Regulation

FDA Balks at CBD Dietary Supplement Application, Maintaining Regulatory Uncertainty

Citing its own approval of CBD as an active ingredient in Epidiolex, the FDA sees the cannabinoid as pharmaceutical constituent.

August 12, 2021

CBD Industry

CBD Sales Both Boosted, Thwarted by COVID-19

Price compression and the economic downturn continue to be challenges, though sales volume has increased.

September 28, 2020

Legislation and Regulation

Maine Says Adult-Use Cannabis Sales Will Launch This Fall, Vermont Revisits Legislation to Tax and Regulate Sales: Week in Review

Maine’s Office of Marijuana Policy announced this week that adult-use sales can launch Oct. 9.

August 22, 2020